Bozeman, MT — Today, Golden Helix, Inc. announced a multi-year partnership with Sentieon, a company that develops bioinformatics secondary analysis tools to process genomic data. This partnership will integrate Sentieon’s secondary analysis tool with Golden Helix software to provide users with a comprehensive solution for genomic data analysis. Sentieon’s suite of secondary analysis tools made […]
Cambridge, UK – Congenica, a world leader in clinical genomics software for inherited diseases, today announced completion of its recently announced Series B funding round with additional investments from new strategically important investors BGI Genomics (BGI), a recognized global leader in genomics, Healthlink Capital (Healthlink), another well-established China-based life-science investor and Future Planet Capital, a global […]
HATFIELD, Pa. — Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia Muro. The overall goal of the partnership is to study the pharmacokinetics and pharmacodynamics of various 3DNA designs and formulations after in vivo administration. Additional aims involve targeting diseases […]
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has signed a distributor agreement in India with Electrolab India Pvt. Ltd. John DiBella, vice president for marketing and sales of Simulations Plus, said: “The Indian pharmaceutical market […]
SAN DIEGO and CAMBRIDGE, ENGLAND –– Congenica and Edico Genome today announced the companies have partnered to offer their complementary platform technologies as an all-in-one, genome data analysis solution that accelerates clinical labs’ and hospitals’ progression from DNA sequencing to diagnosis for inherited diseases, which otherwise can take months or years, while also reducing costs. […]
A certified CDISC provider and leader in pharmacometrics, Certara has developed a new solution which will enable sponsors to achieve new compliance requirements effortlessly PRINCETON, NJ – Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the launch of a new solution for preparing, […]
CAMBRIDGE, Mass.—-Seven Bridges, the biomedical data analysis company, today announced that it has made the Simons Genome Diversity Project (SGDP) dataset available for analysis by researchers via the Seven Bridges Platform. The SGDP is the largest dataset of human genetic variation ever collected, including whole genomes from 300 individuals representing 142 diverse populations across the […]
CAMBRIDGE, Mass. –Seven Bridges, the biomedical data analysis company, today announced that it has made the Simons Genome Diversity Project (SGDP) dataset available for analysis by researchers via the Seven Bridges Platform. The SGDP is the largest dataset of human genetic variation ever collected, including whole genomes from 279 individuals representing 130 diverse populations across the globe. […]
Local sales channel should lead to further penetration of domestic Korean pharmaceutical market Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling & simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has entered into a distributor agreement in South Korea with Quantum Bio Solutions (Q-Bio). John DiBella, vice president […]
Significant update of top-rated program contains enhancements to several modules Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling & simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has released version 9.5 of its flagship PBPK modeling program, GastroPlus™. Dr. Viera Lukacova, team leader and GastroPlus product manager, said: […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
